作者: Bruce E Johnson , Mark G Kris , Lynne D Berry , David J Kwiatkowski , Anthony John Iafrate
DOI: 10.1200/JCO.2013.31.15_SUPPL.8019
关键词:
摘要: 8019 Background: The detection of driver mutations in the EGFR and ALK genes targeted therapy has transformed treatment lung cancer. LCMC was established 2009 to assay adenocarci...